Nucleoside diphosphate kinase (nm23 protein) expression in retinoblastoma

Ophthalmic Research

Volumn 32, Issue 2-3, 2000, Pages 73-78

  Bardak, Yavuz ^a,e   Çekiç, Osman ^b   Ayhan, Ayşe ^c   Günalp, Ilhan ^d   Bulay, Orhan ^d  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SSK Ankara Eye Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

^e NONE   (Turkey)

Author keywords

Metastasis suppressor gene; nm23 gene; Retinoblastoma

Indexed keywords

COMPLEMENTARY DNA; NUCLEOSIDE DIPHOSPHATE KINASE; POLYCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETINOBLASTOMA; STAINING;

EID: 0034081199     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055593     Document Type: Article

References (36)

1. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME: Evidence for a novel gene associated with low tumour metastatic potential. J Natl Cancer Inst 1988;80:200-204.
2. Leone A, Flatow U, King CR, Sandeen MA, Marguiles IMK, Liotta LA, Steeg PS: Reduced tumour incidence, metastatic potential, and cytokine responsiveness of nm23 transfected melanoma cells. Cell 1991;65:25-35.
3. Stahl JA, Leone A, Rosengrad AM, Porter L, King CR, Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 1991;51:445-449.
4. Gilles AM, Presecan E, Vonica A, Lascus I: Nucleoside diphosphate from human erythrocytes: Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991;266:8784-8789.
5. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 1989;49:5185-5189.
6. Hennessy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TWJ: Expression of the antimetastatic gene nm23 in human breast cancer: An association with good prognosis. J Natl Cancer Inst 1991;83:281-285.
7. Hirayama R, Sawai S, Takagi Y, Mishima Y, Kimura N, Shimada N, Esaki Y, Kurashima C, Utsuyama M, Hirokawa K: Positive relationship between expression of the anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 1991;83: 1249-1250.
8. Cohn KH, Ornstein DL, Wang F, LaPaix FD, Phipps K, Edelsberg C, Zuna R, Mott LA, Dunn JL: Association of nm23-H1 allelic deletions with distant metastasis in colorectal carcinoma. Lancet 1991;338:722-724.
9. Ayhan A, Yasui W, Yokosaki H, Kitadai Y, Tahara E: Reduced expression nm23 protein is associated with advanced tumour stage and distant metastasis in human colorectal carcinomas. Virchows Arch B Cell Pathol 1993;63: 213-218.
10. Saraç E, Ayhan A, Ertoy D, Tuncer ZS, Yasui W, Tahara E, Ayhan A: nm23 expression in carcinoma of the uterine cervix. Eur J Gynaecol Oncol 1998;19:312-315.
11. Gunduz M, Ayhan A, Gullu I, Onerci M; Hoşal AS, Gursel IN, Hoşal IN, Firat D: nm23 protein expression in larynx cancer and relationship with metastasis. Eur J Cancer 1997;33: 2338-2341.
12. Ayhan A, Usubütün A, Özen H, Yasui W, Tahara E: Reduced nm23 protein levels in renal cell tumours: The role of the cell type. Oncol Rep 1998;5:979-983.
13. Hailat N, Keim DR, Melhem RF, Zhu X, Eckerskron C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, Hanash SM: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with n-myc gene amplification. J Clin Invest 1991;88:341-345.
14. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Strain D, Slamon DJ, Steeg PS: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neurolbastoma. Oncogene 1993;8:855-865.
15. Abramson DH: Retinoblastoma: Diagnosis and management. Cancer J Clinicians 1982;32: 130-140.
16. Kony SJ, de Vathaire F, Chompret A, Shamsaldim A, Grimaud E, Raquin MA, Oberlin O, Brugieres L, Feunteun J, Eschwege F, Chavaudra J, Lemerle J, Bonaiti-Pellie C: Radiation and genetic factors in the risk of second malignant neoplasm after a first cancer in childhood. Lancet 1997;350:91-95.
17. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-1687.
18. Winick NJ, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, Jacaruso D, Kamen BA, Buchanan GR: Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 1993;11:209-217.
19. Cotran RS, Kumar V, Robbins SL: Robbins' pathologic Basis of Disease, ed 5. Philadelphia, Saunders, 1994, p 18.
20. Nakayama H, Yasui W, Yokozaki H, Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 1993;84:184-190.
21. Abramson DH, Ellsworth RM, Grumbach N, Kitchin FD: Retinoblastonia: Survival, age at detection and comparison 1914-1958, 1958-1983. J Pediatr Ophthalmol Strabismus 1985; 22:246-250.
22. Magramm I, Abramson DH, Ellsworth RM: Optic nerve involvement in retinoblastoma. Ophthalmology 1989;96:217-222.
23. Shields CL, De Potter P, Himelstein BP, Shields JA: Chemoreduction in the initial management of intraoculer retinoblastoma. Arch Ophthalmol 1996;114:1330-1338.
24. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD Jr: Mortality from second tumours among the long term survivors of retinblastoma. J Natl Cancer Inst 1993;85:1121-1128.
25. Imhof SM, Hofman P, Tan KE: Quantification of lacrimal function after D-shaped field irradiation for retinoblastoma. Br J Ophthalmol 1993;77:482-484.
26. MacFaul PA, Bedford MA: Ocular complication after therapeutic irradiation. Br J Ophthalmol 1970;54:237-247.
27. Kobrin JL, Blodi FC: Prognosis in retinoblastoma: Influence of histopathologic characteristics. J Pediatr Ophthalmol Strabismus 1978; 15:278-281.
28. Stannard C, Lipper S, Sealy R, Sevel D: Retinoblastoma: Correlation of invasion of the optic nerve and choroid with prognosis and metastasis. Br J Ophthalmol 1979;63:560-570.
29. Messmer EP, Heinrich T, Hopping W, DeSutter E, Havers W, Sauerwein W: Risk factors for metastasis in patients with retinoblastoma. Ophthalmology 1991;98:136-141.
30. Olver J, McCartney ACE, Kingston J, Hungerford J: Histological indicators of the prognosis for survival following enucleation for retinoblastoma; in Bornfeld N, Gragoudas ES, Hopping W, Lommatzsch PK (eds): Tumours of the Eye. New York, Kugler, 1991, pp 59-67.
31. Rootman J, Hofbauer J, Ellsworth RM, Kitchen D: Invasion of the optic nerve by retinoblastoma: A clinicopathologic study. Can J Ophthalmol 1976;11:106-114.
32. Zimmerman LE: The registry of ophthalmic pathology: Past, present, and future. 17th Jackson Memorial Lecture. Trans Am Acad Ophthalmol Otolaryngol 1961;65:51-113.
33. Shields CL, Shields JA, Baez KA, Cater J, De Poter PV: Choroidal invasion of retinoblastoma: Metastatic potential and clinical risk factors. Br J Ophthalmol 1993;77:544-548.
34. Higashiyama M, Doi O, Yokouchi H, Kodama K, Nakamori S, Tateishi S, Kimura N: Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adencoracinoma: Lack of prognostic value. Br J Cancer 1992;66:533-536.
35. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, Kimura N, Nagataki S: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of nm23 gene product. J Natl Cancer Inst 1992;84:1349-1354.
36. Ma D, Luyten GP, Luider TM, Jager MJ, Niederkorn JY: Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model. Invest Ophthalmol Vis Sci 1996;37:2293-2301.